Merit Medical Systems Stock Hits New 52-Week High (MMSI)

NEW YORK (TheStreet) -- Merit Medical Systems (Nasdaq:MMSI) hit a new 52-week high Monday as it traded at $20.32 compared with its previous 52-Week high of $20.28. Merit Medical Systems is changing hands at $20.30 with 17,776 shares traded as of 12:31 p.m. ET. Average volume has been 185,800 shares over the past 30 days.

Merit Medical Systems has a market cap of $559.1 million and is part of the health care sector and health services industry.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company's cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions.

• Practice your MMSI trading strategies and win cash in our stock game.

TheStreet Ratings rates Merit Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Merit Medical Systems Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

For more information on Merit Medical Systems click any of the following:

• Merit Medical Systems Stock Price

• Merit Medical Systems Analyst Ratings

• Merit Medical Systems Key Stats & Profile

• Merit Medical Systems Earnings

• Merit Medical Systems Ratio Comparison

• Merit Medical Systems Growth Rates

• Merit Medical Systems Balance Sheet

• Merit Medical Systems Cash Flow

• Merit Medical Systems Income Statement